Table 1.
Demographic, clinical and biological characteristics of the study population
| All (N = 1559) | Hypertensive (N = 600) | Normotensive (N = 959) | P | |
|---|---|---|---|---|
| Demographic characteristics | ||||
| Age, y | 47.3 ± 17.1 | 55.8 ± 15.0 | 42.0 ± 16.2 | <0.001 |
| Male, N (%) | 729 (46.8) | 304 (50.7) | 425 (44.3) | 0.01 |
| BMI, kg/m2 | 28.2 ± 5.7 | 30.3 ± 5.5 | 26.6 ± 5.1 | <0.001 |
| Anti‐hypertensive treatment, N (%) | – | 412 (68.7) | – | NA |
| Systolic blood pressure, mmHg | 133.9 ± 21.4 | 147.9 ± 22.2 | 125.0 ± 15.2 | <0.001 |
| Diastolic blood pressure, mmHg | 84.7 ± 11.9 | 90.9 ± 12.2 | 80.9 ± 10.0 | <0.001 |
| Heart rate, beats/min | 76.7 ± 11.4 | 76.9 ± 11.9 | 76.6 ± 11.0 | 0.59 |
| Laboratory values | ||||
| Serum uric acid, mg/dL | 4.9 ± 1.3 | 5.2 ± 1.4 | 4.7 ± 1.2 | <0.001 |
| eGFR, mL/min per 1.73 m2 | 100.6 ± 16.8 | 94.1 ± 15.2 | 104.6 ± 16.6 | <0.001 |
| HDL‐Cholesterol, mg/dL | 55.4 ± 16.5 | 54.1 ± 16.9 | 56.1 ± 16.3 | 0.02 |
| LDL‐Cholesterol, mg/dL | 128.8 ± 40.2 | 134.4 ± 40.9 | 125.3 ± 39.4 | <0.001 |
| Urinary albumin/creatinine ratio, mg/g | 3.9 (2.5‐6.9) | 4.5 (2.7‐7.7) | 3.6 (2.4‐6.4) | <0.001 |
| Serum glucose, mg/dL | 97.0 (90.0‐106.0) | 101.0 (94.0‐114.5) | 94.0 (88.0‐102.0) | <0.001 |
| HbA1c | 5.3 (5.1‐5.7) | 5.5 (5.2‐5.9) | 5.2 (5.0‐5.5) | <0.001 |
| Urinary sodium, mmol/d | 209.4 ± 67.4 | 227.3 ± 69.7 | 198.2 ± 63.4 | <0.001 |
| Pulse wave velocity, m/s | 8.2 (7.1‐9.9) | 9.4 (8.0‐11.0) | 7.6 (6.6‐8.9) | <0.001 |
Data are expressed as mean ± SD, median with IR, or percent frequency, as appropriate.